Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.2150
-0.0010 (-0.46%)
Streaming Delayed Price
Updated: 3:57 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
156,694
Open
0.2190
Bid (Size)
0.2030 (4)
Ask (Size)
0.2158 (6)
Prev. Close
0.2160
Today's Range
0.2008 - 0.2200
52wk Range
0.1900 - 2.750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
May 20, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
May 20, 2024
Via
ACCESSWIRE
Performance
YTD
-81.93%
-81.93%
1 Month
+7.99%
+7.99%
3 Month
-25.86%
-25.86%
6 Month
-89.71%
-89.71%
1 Year
-89.97%
-89.97%
More News
Read More
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
May 16, 2024
Via
Investor Brand Network
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q1 2024
May 16, 2024
Via
InvestorPlace
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
May 16, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at the LSX World Congress 2024
April 23, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
April 21, 2024
Via
ACCESSWIRE
New Research Sheds Light on the Initial Stages of Brain Cancer Development
March 18, 2024
Via
Investor Brand Network
New mRNA Vaccine Offers Hope Against Glioblastoma
May 15, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 09, 2024
Via
Benzinga
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
April 26, 2024
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
April 23, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
April 22, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 22, 2024
Via
Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
April 15, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 08, 2024
Via
Benzinga
Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
April 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
April 02, 2024
Via
Investor Brand Network
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023
April 01, 2024
Via
InvestorPlace
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at Two Investor Conferences in April
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
March 18, 2024
Via
Investor Brand Network
Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
February 26, 2024
Via
Investor Brand Network
Top 5 Health Care Stocks That Are Preparing To Pump In February
February 09, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.